The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats

Chemico-Biological Interactions

Volumn 237, Issue , 2015, Pages 18-24

  Kumar, Munipally Praveen ^a   Sankeshi, Venu ^a   Naik, R Ravindar ^b   Thirupathi, P ^c   Das, Biswanath ^c   Raju, T N ^a  

^a OSMANIA UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Aldose reductase; Aldose reductase inhibitors; Diabetic retinopathy; Enzyme kinetics and molecular docking; Oxidative stress

Indexed keywords

3,6,7,4',5' PENTAMETHOXY 5,3' DIHYDROXYFLAVONE; ALDEHYDE REDUCTASE; CATALASE; ENZYME INHIBITOR; GLUTATHIONE PEROXIDASE; SORBITOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE; STREPTOZOCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAESALPINIA PULCHERRIMA; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROGEN BOND; HYDROPHOBICITY; IC50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FABACEAE; INFRARED SPECTROPHOTOMETRY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; RETINA;

CAESALPINIA PULCHERRIMA; RATTUS;

ALDEHYDE REDUCTASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME INHIBITORS; FABACEAE; INHIBITORY CONCENTRATION 50; ISOFLAVONES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR DOCKING SIMULATION; RATS; RETINA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; STREPTOZOCIN;

EID: 84929580054     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.05.010     Document Type: Article

References (51)

1. J.M. Furtado, V.C. Lansingh, M.J. Carter, M.F. Milanese, B.N. Pena, H.A. Ghersi, P.L. Bote, M.E. Nano, and J.C. Silva Causes of blindness and visual impairment in Latin America Surv. Ophthalmol. 57 2012 149 177
2. M. Rema, P. Sujatha, and R. Pradeepa Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors Indian J. Ophthalmol. 53 2005 93 99
3. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
4. J.H. Kinoshita A thirty year journey in the polyol pathway Exp. Eye Res. 50 1990 567 573
5. K.H. Gabbay The sorbitol pathway and the complications of diabetes N. Engl. J. Med. 288 1973 831 836
6. J.R. Williamson, K. Chang, M. Frangos, K.S. Hasan, Y. Ido, T. Kawamura, J.R. Nyengaard, M. van den Enden, C. Kilo, and R.G. Tilton Hyperglycemic pseudohypoxia and diabetic complications Diabetes 42 1993 801 813
7. S.S. Chung, E.C. Ho, K.S. Lam, and S.K. Chung Contribution of polyol pathway to diabetes-induced oxidative stress J. Am. Soc. Nephrol. 14 2003 S233 S236
8. A.Y. Lee, S.K. Chung, and S.S. Chung Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens Proc. Natl. Acad. Sci. U.S.A. 92 1995 2780 2784
9. R.N. Frank, R. Amin, A. Kennedy, and T.C. Hohman An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia Arch. Ophthalmol. 115 1997 1036 1047
10. R.A. Kowluru, J. Tang, and T.S. Kern Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy Diabetes 50 2001 1938 1942
11. B.A. Berkowitz, Y. Ito, T.S. Kern, C. McDonald, and R. Hawkins Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 42 2001 2964 2969
12. W.G. Robison Jr., P.F. Kador, and J.H. Kinoshita Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor Science 221 1983 1177 1179
13. J.H. Kinoshita, and C. Nishimura The involvement of aldose reductase in diabetic complications Diabetes Metab. Rev. 4 1988 323 337
14. P.J. Oates, and B.L. Mylari Aldose reductase inhibitors: therapeutic implications for diabetic complications Expert Opin. Invest. Drugs 8 1999 2095 2119
15. A. Bhatnagar, and S.K. Srivastava Aldose reductase: congenial and injurious profiles of an enigmatic enzyme Biochem. Med. Metab. Biol. 48 1992 91 121
16. P.F. Kador, J.H. Kinoshita, and N.E. Sharpless Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications J. Med. Chem. 28 1985 841 849
17. P.F. Kador, W.G. Robison Jr., and J.H. Kinoshita The pharmacology of aldose reductase inhibitors Annu. Rev. Pharmacol. Toxicol. 25 1985 691 714
18. M.A. Pfeifer, M.P. Schumer, and D.A. Gelber Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 46 Suppl. 2 1997 S82 S89
19. N. Hotta, T. Toyota, K. Matsuoka, Y. Shigeta, R. Kikkawa, T. Kaneko, A. Takahashi, K. Sugimura, Y. Koike, J. Ishii, N. Sakamoto S.N.K.D.N.S. Group Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study Diabetes Care 24 2001 1776 1782
20. P. Raskin, and J. Rosenstock Aldose reductase inhibitors and diabetic complications Am. J. Med. 83 1987 298 306
21. N. Kato, S. Yashima, T. Suzuki, Y. Nakayama, and T. Jomori Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats J. Diabetes Complications 17 2003 374 379
22. J.K. Grover, S. Yadav, and V. Vats Medicinal plants of India with anti-diabetic potential J. Ethnopharmacol. 81 2002 81 100
23. A.Y. Oubre, T.J. Carlson, S.R. King, and G.M. Reaven From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM Diabetologia 40 1997 614 617
24. S.K. Swanston-Flatt, P.R. Flatt, C. Day, and C.J. Bailey Traditional dietary adjuncts for the treatment of diabetes mellitus Proc. Nutr. Soc. 50 1991 641 651
25. J. Chang Medicinal herbs: drugs or dietary supplements? Biochem. Pharmacol. 59 2000 211 219
26. P.B. Kaufman, J.A. Duke, H. Brielmann, J. Boik, and J.E. Hoyt A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health J. Altern. Complement. Med. 3 1997 7 12
27. H. Duan, J. Huang, W. Li, and M. Tang Protective effects of fufang xueshuantong on diabetic retinopathy in rats Evid. Based Complement. Altern. Med. 2013 2013 408268
28. V. Sankeshi, P.A. Kumar, R.R. Naik, G. Sridhar, M.P. Kumar, V.V. Gopal, and T.N. Raju Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract J. Ethnopharmacol. 149 2013 215 221
29. P. Suryanarayana, P.A. Kumar, M. Saraswat, J.M. Petrash, and G.B. Reddy Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract Mol. Vis. 10 2004 148 154
30. H.A. Jung, N.Y. Yoon, H.J. Bae, B.S. Min, and J.S. Choi Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase Arch. Pharm. Res. 31 2008 1405 1412
31. D. Patel, R. Kumar, M. Kumar, K. Sairam, and S. Hemalatha Evaluation of in vitro aldose reductase inhibitory potential of different fraction of Hybanthus enneaspermus Linn F. Muell. Asian Pac. J. Trop. Biomed. 2 2012 134 139
32. B. Wermuth, H. Burgisser, K. Bohren, and J.P. von Wartburg Purification and characterization of human-brain aldose reductase Eur. J. Biochem. 127 1982 279 284
33. T.H. Kim, J.K. Kim, Y.H. Kang, J.Y. Lee, I.J. Kang, and S.S. Lim Aldose reductase inhibitory activity of compounds from Zea mays L. Biomed Res. Int. 2013 2013 727143
34. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
35. P. BrahmaNaidu, H. Nemani, B. Meriga, S.K. Mehar, S. Potana, and S. Ramgopalrao Mitigating efficacy of piperine in the physiological derangements of high fat diet induced obesity in Sprague Dawley rats Chem. Biol. Interact. 221 2014 42 51
36. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
37. T. Matsunami, Y. Sato, T. Sato, and M. Yukawa Antioxidant status and lipid peroxidation in diabetic rats under hyperbaric oxygen exposure Physiol. Res. 59 2010 97 104
38. K. Uchida, M. Kanematsu, K. Sakai, T. Matsuda, N. Hattori, Y. Mizuno, D. Suzuki, T. Miyata, N. Noguchi, E. Niki, and T. Osawa Protein-bound acrolein: potential markers for oxidative stress Proc. Natl. Acad. Sci. U.S.A. 95 1998 4882 4887
39. S. Marklund, and G. Marklund Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 1974 469 474
40. A.K. Sinha Colorimetric assay of catalase Anal. Biochem. 47 1972 389 394
41. R.A. Lawrence, R.A. Sunde, G.L. Schwartz, and W.G. Hoekstra Glutathione peroxidase activity in rat lens and other tissues in relation to dietary selenium intake Exp. Eye Res. 18 1974 563 569
42. B.D. Bursulaya, M. Totrov, R. Abagyan, and C.L. Brooks 3rd Comparative study of several algorithms for flexible ligand docking J. Comput. Aided Mol. Des. 17 2003 755 763
43. M. Stahl, and M. Rarey Detailed analysis of scoring functions for virtual screening J. Med. Chem. 44 2001 1035 1042
44. J. Peyroux, and M. Sternberg Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes Pathol. Biol. (Paris) 54 2006 405 419
45. A. Ardestani, and R. Yazdanparast Inhibitory effects of ethyl acetate extract of Teucrium polium on in vitro protein glycoxidation Food Chem. Toxicol. 45 2007 2402 2411
46. S.S. Chung, and S.K. Chung Aldose reductase in diabetic microvascular complications Curr. Drug Targets 6 2005 475 486
47. S. Chakrabarti, N. Ma, and A.A. Sima Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-rat Diabetologia 32 1989 826 828
48. J.P. Glover, J.L. Jacot, M.D. Basso, T.C. Hohman, and W.G. Robison Jr. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model J. Ocul. Pharmacol. Ther. 16 2000 167 172
49. T.S. Lee, L.C. MacGregor, S.J. Fluharty, and G.L. King Differential regulation of protein kinase C and (Na, K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells J. Clin. Invest. 83 1989 90 94
50. B. Lassegue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 2003 R277 R297
51. P.A. Barnett, R.G. Gonzalez, L.T. Chylack Jr., and H.M. Cheng The effect of oxidation on sorbitol pathway kinetics Diabetes 35 1986 426 432